Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-10 · accession 0001193125-26-047313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-11 | 2026-02-10 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $1.05 | +16.9K | 706.5K | +2% | +$17.7K |
| D | 2026-02-11 | 2026-02-10 | TMCI | Scanlan Sean F. | Chief Innovation Off | M - OptEx | $0.00 | -16.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | M | A | 16,875 | $1.05 | 706,474 | D | — | — | (F1) Includes 511, 291 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-10 | M | D | 16,875 | $0.00 | 0 | D | $1.05 · 2021-01-30 to 2027-01-30 | 16,875 Common Stock | (F2) The stock option vested in equal annual installments over 4 years, commencing on January 30, 2017 with the last installment vesting on January 30, 2021. |